Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Oregon Health & Science University Knight Cancer Institute
3181 S.W. Sam Jackson Park RoadPortland, Oregon, United States
Email Phone Web
The Oregon Health & Science University (OHSU) Knight Cancer Institute, known as one of the pioneers in personalized cancer medicine, is an international leader in research and cancer treatment. Driven by its mission to end cancer, the institute is building upon its expertise in targeted treatments to advance the early detection of cancer when the disease is most treatable.
OHSU Knight Cancer Institute Director Brian Druker, M.D., revolutionized the treatment of cancer through research that resulted in the first drug to target the molecular defect of a cancer while leaving healthy cells unharmed. Marketed under the name Gleevec®, his discovery turned a once-fatal cancer, chronic myeloid leukemia, into a manageable condition.
At the OHSU Knight Cancer Institute, a team of doctors, nurses and therapists is dedicated to diagnosing, treating and managing amyloidosis. Their amyloidosis doctors have extensive knowledge about amyloidosis diagnosis and treatment and meet weekly to discuss all patients, benefiting them of the entire team’s knowledge and expertise.
Healthcare professionals at Oregon Health & Science University specialise in the following areas:
Thomas G. DeLoughery, MD, MACP, FAWM; Eva Medvedova, MD
Cardiology:
Catherine Wong, MD
Nephrology:
Rupali S. Avasare, MD
Related Content
-
The Amyloidosis Center at Boston University School of Medicine and Boston Medical CenterThe Amyloidosis Center at Boston Univers...
-
Webinar on the Impact of Myeloma and AL Amyloidosis in Carershttps://www.youtube.com/watch?v=8EwYg826...
-
Froedtert Hospital Cancer CenterFroedtert Hospital Cancer Center gives...
-
Marie Lugtu, RNMarie Lugtu graduated from the Universit...
-
Mayo Clinic Patient Symposium in Plasma Cell Disorders 2021: Patient and Family RegistrationMayo Clinic School of Continuous Profess...
-
Mary O’DonnellMary O'Donnell is President/CEO at Amylo...
-
Karmanos Cancer InstituteKarmanos Cancer Institute, headquartered...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.